150 related articles for article (PubMed ID: 2218655)
1. Acute promyelocytic leukemia: impact of hemorrhagic complications on response to induction chemotherapy and survival.
Humphries JE; Hess CE; Stewart FM
South Med J; 1990 Oct; 83(10):1157-61. PubMed ID: 2218655
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
[TBL] [Abstract][Full Text] [Related]
4. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
Bassan R; Battista R; Viero P; d'Emilio A; Buelli M; Montaldi A; Rambaldi A; Tremul L; Dini E; Barbui T
Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
[TBL] [Abstract][Full Text] [Related]
5. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
6. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
[TBL] [Abstract][Full Text] [Related]
7. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
8. Disseminated intravascular coagulation in acute promyelocytic leukaemia and its impact on the induction failure: a single centre study.
Rahman F; Kabir AL; Khan MR; Aziz A; Baqui MN; Dipta TF; Yunus AB
Bangladesh Med Res Counc Bull; 2013 Aug; 39(2):57-60. PubMed ID: 24930192
[TBL] [Abstract][Full Text] [Related]
9. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment by a drainage of subdural hematoma in a case of intracranial hemorrhage due to DIC complicated with acute promyelocytic leukemia].
Nakagawa T; Imoto S; Ito M; Taomoto K; Yamada H; Saito S; Okamura A
Rinsho Ketsueki; 1989 Jun; 30(6):874-7. PubMed ID: 2795898
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
Testa U; Lo-Coco F
Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
13. Persistence of retinoic acid sensitivity in relapsed acute promyelocytic leukemia with extramedullary involvement.
Thomas X; Fiere D; Archimbaud E
Leukemia; 1994 Mar; 8(3):520-1. PubMed ID: 8127158
[No Abstract] [Full Text] [Related]
14. [Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage].
Koi S; Nogami A; Fujiwara H; Bando K; Saito M; Osada Y; Tanaka K; Sakashita C; Yoshifuji K; Okada K; Umezawa Y; Nagao T; Yamamoto M; Mori T
Rinsho Ketsueki; 2023; 64(11):1426-1430. PubMed ID: 38072429
[TBL] [Abstract][Full Text] [Related]
15. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
16. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience.
Akcay OF; Yeter HH; Buyukasik Y
Rom J Intern Med; 2020 Sep; 58(3):138-145. PubMed ID: 32452194
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhage.
Feldman EJ; Arlin ZA; Ahmed T; Mittelman A; Ascensao JL; Puccio CA; Coombe N; Baskind P
Acta Haematol; 1989; 82(3):117-21. PubMed ID: 2510432
[TBL] [Abstract][Full Text] [Related]
18. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of disseminated intravascular coagulation in 18 cases of promyelocytic acute leukaemia (author's transl)].
Dreyfus B; Varet B; Heilmann-Gouault M; Sultan C; Reyes F; Gluckman E; Basch A; Beaujean F
Nouv Rev Fr Hematol; 1973; 13(6):761-70. PubMed ID: 4280042
[No Abstract] [Full Text] [Related]
20. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
